Chiara Castelli

13.8k citations

127 papers · 10.2k indexed · 6 hit papers · h-index 46

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research

Papers in

Immunology 100
- Immunotherapy and Immune Responses 79
- Immune Cell Function and Interaction 38
- T-cell and B-cell Immunology 36
- Immune cells in cancer 11
Oncology 59
- CAR-T cell therapy research 24
- Cancer Immunotherapy and Biomarkers 23
- Cancer Cells and Metastasis 8

Co-authors: Giorgio Parmiani Licia Rivoltini Piero Dalerba Luisa Novellino Veronica Huber Nicolina Renkvist Chiara Camisaschi Paul F. Robbins
Journals: The Journal of Immunology (12 papers)Cancer Immunology Immunotherapy (9 papers)International Journal of Cancer (8 papers)Clinical Cancer Research (6 papers)Cancer Research (5 papers)
Partner nations: Italy United States France

In The Last Decade

Chiara Castelli

127 papers receiving 10.0k citations

Hit Papers

6 papers align trajectories log scale

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease 2018 · 503 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Hepatology
2017 Seminars in Cancer Biology
2007 Journal of Clinical Oncology
2007 Proceedings of the National Academy of Sciences
2002 The Journal of Experimental Medicine
2001 Cancer Immunology Immunotherapy

Peers

Countries citing papers authored by Chiara Castelli

Since Specialization

Citations

This map shows the geographic impact of Chiara Castelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Castelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Castelli more than expected).

Fields of papers citing papers by Chiara Castelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Castelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Castelli. The network helps show where Chiara Castelli may publish in the future.

Co-authors

The 25 scholars most cited alongside Chiara Castelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chiara Castelli Line = papers co-authored together Chiara Castelli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade Scientific Reports ·Licia Rivoltini, Chiara Camisaschi, Giovanni Fucà, Biagio Paolini, Barbara Vergani, Kanila Putri, Silvia Damian, Matteo Duca, Sara Cresta, Michele Magni, Biagio Eugenio Leone, Chiara Castelli, Filippo de Braud, Francesca De Santis, Massimo Di Nicola	2024	6
2	Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients SHILAP Revista de lepidopterología ·Darawan Rinchai, Elena Verzoni, Veronica Huber, Agata Cova, Paola Squarcina, Loris De Cecco, Filippo de Braud, Raffaele Ratta, Matteo Dugo, Luca Lalli, Viviana Vallacchi, Monica Rodolfo, Jessica Roelands, Chiara Castelli, Damien Chaussabel, Giuseppe Procopio, Davide Bedognetti, Licia Rivoltini	2021	5
3	Extracellular vesicles in anti-tumor immunity Seminars in Cancer Biology ·Elisabetta Vergani, Elena Daveri, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, Chiara Castelli, Monica Rodolfo, Licia Rivoltini, Veronica Huber	2021	37
4	Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention International Journal of Molecular Sciences ·Marcella Tazzari, Laura Bergamaschi, Alessandro De Vita, Paola Collini, Marta Barisella, Alessia Bertolotti, Toni Ibrahim, Sandro Pasquali, Chiara Castelli, Viviana Vallacchi	2021	23
5	Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial–Mesenchymal Transition–like Process and 22q Loss Molecular Cancer Research ·Silvia Stacchiotti, Annalisa Astolfi, Alessandro Gronchi, Andrea Fontana, Maria A. Pantaleo, Tiziana Negri, Monica Brenca, Marcella Tazzari, Milena Urbini, Valentina Indio, Chiara Colombo, Stefano Radaelli, Silvia Brich, Angelo Paolo Dei Tos, Paolo G. Casali, Chiara Castelli, Gian Paolo Dagrada, Silvana Pilotti, Roberta Maestro	2016	23
6	microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response Genes ·Viviana Vallacchi, Chiara Camisaschi, Matteo Dugo, Elisabetta Vergani, Paola Deho, Ambra V. Gualeni, Veronica Huber, Annunziata Gloghini, Andrea Maurichi, Mario Santinami, Marialuisa Sensi, Chiara Castelli, Licia Rivoltini, Monica Rodolfo	2016	8
7	Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer Vaccines ·Chiara Camisaschi, Viviana Vallacchi, Elisabetta Vergani, Marcella Tazzari, Simona Ferro, Alessandra Tuccitto, Olga Kuchuk, Eriomina Shahaj, Linda Aaltonen, Chiara Castelli, Monica Rodolfo, Licia Rivoltini, Veronica Huber	2016	22
8	Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents Clinical Cancer Research ·I. Jolanda M. de Vries, Chiara Castelli, 賢二石沢, Joannes F.M. Jacobs, Julie Stockis, Beatrice Schuler‐Thurner, Gosse J. Adema, Cornelis J.A. Punt, Licia Rivoltini, Gerold Schuler, Pierre G. Coulie, Sophie Lucas	2010	64
9	LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites The Journal of Immunology ·Chiara Camisaschi, Chiara Casati, Francesca Rini, Michela Perego, Annamaria De Filippo, Frédéric Triebel, Giorgio Parmiani, Filiberto Belli, Licia Rivoltini, Chiara Castelli	2010	271
10	Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1 Clinical Cancer Research ·Cristina Maccalli, Veronica Di Cristanziano, Valentina Fodale, Domenico Corsi, Giuseppina D’Agostino, Valentina Petrangeli, Luca Laurenti, Andrew Lawman, Arabella Mazzocchi, Flavio Arienti, Maria Paola Perrone, Chiara Castelli, Licia Rivoltini, Vittorina Zagonel, Marco Tartaglia, Giorgio Parmiani, Filippo Belardelli	2008	8
11	Human Lymphocyte Activation Gene-3 Molecules Expressed by Activated T Cells Deliver Costimulation Signal for Dendritic Cell Activation The Journal of Immunology ·Chiara Casati, Chiara Camisaschi, Luisa Novellino, Arabella Mazzocchi, Frédéric Triebel, Licia Rivoltini, Giorgio Parmiani, Chiara Castelli	2008	15
12	NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients Clinical Cancer Research ·Cristina Maccalli, Daisuke Nonaka, Adriano Piris, Daniela Pende, Licia Rivoltini, Chiara Castelli, Giorgio Parmiani	2007	24
13	Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials The Journal of Immunology ·Giorgio Parmiani, Annamaria De Filippo, Luisa Novellino, Chiara Castelli	2007	120
14	Soluble Human LAG-3 Molecule Amplifies the In vitro Generation of Type 1 Tumor-Specific Immunity Cancer Research ·Chiara Casati, Chiara Camisaschi, Francesca Rini, Flavio Arienti, Licia Rivoltini, Frédéric Triebel, Giorgio Parmiani, Chiara Castelli	2006	60
15	Reconstitution of Human Telomerase Reverse Transcriptase Expression Rescues Colorectal Carcinoma Cells from In vitro Senescence: Evidence against Immortality as a Constitutive Trait of Tumor Cells Cancer Research ·Piero Dalerba, Cristiana Guiducci, Pietro Luigi Poliani, Ingrid Cifola, Mariella Parenza, Milo Frattini, Gianfrancesco Gallino, Ileana Carnevali, A Line, Salvatore Andreola, Claudia Lombardo, Licia Rivoltini, Tamás Schweighoffer, Filiberto Belli, Mario P. Colombo, Giorgio Parmiani, Chiara Castelli	2005	22
16	Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells The Journal of Immunology ·Licia Rivoltini, Chiara Castelli, Matteo Giovanni Carrabba, Vincenzo Mazzaferro, Lorenzo Pilla, Veronica Huber, Jorgelina Coppa, Gianfrancesco Gallino, Carmen Scheibenbogen, Paola Squarcina, Agata Cova, Roberto Camerini, Jonathan J. Lewis, Pramod K. Srivastava, Giorgio Parmiani	2003	93
17	Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen The Journal of Immunology ·Luisa Novellino, Nicolina Renkvist, Francesca Rini, Arabella Mazzocchi, Licia Rivoltini, Angela Greco, Paola Deho, Paola Squarcina, Paul F. Robbins, Giorgio Parmiani, Chiara Castelli	2003	38
18	Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes The Journal of Immunology ·Elke Jäger, Russell D. Salter, Chiara Castelli, Hanni Höhn, Kirsten Freitag, Julia Karbach, Claudia Neukirch, Antje Necker, Alexander Knuth, Markus Maeurer	2002	6
19	Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A International Journal of Cancer ·G. Malfatto, Shweta U. Dongare, Julia Karbach, Frank Momburg, Chiara Castelli, Alexander Knuth, Barbara Seliger, Markus Maeurer	1999	11
20	[Myocardial infarction in young people. A coronary angiographic study in 21 patients under the age of 30 (author's transl)]. PubMed ·夏雁楠, L. D. Pullen, Gagel, Jamal Gumati, Chiara Castelli, M. Xu	1978	1

About Chiara Castelli

Chiara Castelli is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Gastroenterology, having authored 127 papers that have together received 10.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (79 papers), Immune Cell Function and Interaction (38 papers), T-cell and B-cell Immunology (36 papers), CAR-T cell therapy research (24 papers), Cancer Immunotherapy and Biomarkers (23 papers), vaccines and immunoinformatics approaches (21 papers), Immune cells in cancer (11 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Immunology (5.8k citations), Oncology (4.8k citations), Cancer Research (1.3k citations), Molecular Biology (4.4k citations) and Biotechnology (477 citations). Chiara Castelli has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Giorgio Parmiani, Licia Rivoltini, Piero Dalerba, Luisa Novellino, Veronica Huber, Nicolina Renkvist, Chiara Camisaschi, Paul F. Robbins, Lorenzo Pilla and Emina H. Huang. Their work appears in journals such as The Journal of Immunology, Cancer Immunology Immunotherapy, International Journal of Cancer, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact